Summary
The objective of this study was to examine diabetic patients at the time of admission to maintenance haemodialysis and to follow them for 36 months in order to define predictors of cardiovascular and non-cardiovascular death. This prospective study comprised all consecutive diabetic patients admitted to 28 German dialysis centres between January 1985 and October 1987; 196 patients were examined, 67 Type 1 (insulin-dependent) diabetic (43 male, 24 female; median age 49 years, range 22–73) and 129 Type 2 (non-insulin-dependent) diabetic patients (54 male, 75 female; 64 years, range 37–82).
Outcome measures were death, i.e. myocardial infarction, sudden death, cardiac death of other causes, stroke and noncardiovascular death. Actuarial survival 36 months after the beginning of dialysis was similar in Type 1 (40%) and Type 2 diabetic patients (43%) despite the age difference. Causes of death were myocardial infarction (18%), sudden death (18%), other cardiac causes (18%); stroke (6%); septicaemia (17%) mostly originating from diabetic foot problems; and interruption of therapy. Survival rates and the proportion dying from cardiac causes were similar in patients with diabetic nephropathy or with other primary chronic renal disease and coincidental diabetes. On dialysis, de novo amaurosis or de novo amputation was not observed in any patient. The strongest predictor of myocardial infarction or sudden death was serum lipids on admission. Duration of hypertension, blood pressure at the time of admission to dialysis, left ventricular hypertrophy or end-diastolic diameter by echocardiography, Sokolow index and average predialysis blood pressure, smoking, interdialytic weight gain and type of dialysis were not predictive of cardiovascular death or death by all causes. Patients with myocardial infarction were more frequently male (70% of myocardial infarction), tended to be younger, more frequently had a history of myocardial infarction (relative risk 3.0) and more frequently had angina pectoris, proliferative retinopathy (relative risk 2.8) or somatosensory polyneuropathy (relative risk 3.0). Patients dying from myocardial infarction or other cardiac causes had more frequent episodes of intradialytic hypotension and tended to be less frequently on beta blocker treatment.
We conclude that cardiac death accounts for most fatalities of diabetic patients on dialysis. Some, but not all, classic risk factors are predictive of cardiac death.
Similar content being viewed by others
References
Ghavamian M, Gutch CG, Kopp KF, Kolff WJ (1972) The sad truth about hemodialysis in diabetic nephropathy. J Am Med Assoc 222: 1386–1389
Ritz E, Koch M (1992) Renal failure in diabetic nephropathy. In: Cameron ST, Davison AM, Grünfeld JP, Kerr D, Ritz E (eds), Oxford textbook of clinical nephrology. Oxford University Press, Oxford, pp 1635–1676
Brunner FP, Selwood N (1992) Profile of patients on RRT in Europe and death rates due to major causes of death groups. Kidney Int [Suppl 38]: S4–S15
National Diabetes Data Group (1979): Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039–1057
WHO Expert Committee on Diabetes mellitus (1980) World Health Organisation Technical Report Series 640, Geneva
Koch M, Tschöpe W, Ritz E (1991) Ist die Betreuung niereninsuffizienter Diabetiker in der prädialytischen Phase verbesserungsbedürftig? Dtsch Med Wschr 116: 1543–1548
Frisancho AR (1974) Triceps skin fold and upper arm muscle size norms for assessment of nutritional status. Am J Clin Nutr 27: 1052–1058
Blumenkrantz MJ, Kopple JD, Gutmann RA et al. (1980) Methods for assessing nutritional status of patients with renal failure. Am J Clin Nutr 33: 1567–1585
Mann J, Ritz E (1990) Arterielle Hypertonie. In: Schettler G, Greton H (eds), Innere Medizin, 8. Aufl., Thieme Verlag, Stuttgart, pp 159–194
Devereux RB (1990) Evaluation of cardiac structure and function by echocardiography and other noninvasive techniques. In: Laragh JH, Brenner BM (eds) Hypertension: pathophysiology, diagnosis and management. Raven Press Ltd., New York, 1479–1492
Lipid Research Clinics Program (1984) The Lipid Research Clinics Coronary Primary Prevention Trials Results. JAMA 251: 451–474
Koch M (1989) Prävalenz kardiovaskulärer Ereignisse und kardiovaskulärer Risikofaktoren bei hämodialysierten Diabetikern. Doctoral Thesis, University of Heidelberg
Brunner FP, Broyer M, Brynger H et al. (1988) Survival on renal replacement therapy. Data from the EDTA Registry. Nephrol Dial Transplant 2: 109–122
Ritz E, Strumpf C, Katz F, Wing AJ, Quellhorst E (1985) Hypertension and cardiovascular risk factors in hemodialyzed diabetic patients. Hypertension 7 [Suppl 2]: II-118–II-124
United States Renal Data System (1991) Annual data report. Am J Kidney Dis 18 [Suppl 2]
Charra B, Calemard E, Ruffet M et al. (1992) Survival as an index of adequacy of dialysis. Kidney Int 41: 1286–1291
Silberberg JS, Barre PE, Prichard SS, Sniderman AD (1989) Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 36: 286–290
Ritz E, Ruffmann K, Rambausek M, Mall G, Schmidli M (1987) Dialysis hypotension — is it related to diastolic left ventricular malfunction? Nephrol Dial Transplant 2: 293–297
Degoulot P, Legrain M, Reach I (1982) Mortality risk factors in patients treated by chronic hemodialysis. Nephron 31: 103–110
Lowrie EG, Lew NL (1990) Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15: 458–482
Held PJ, Brunner F, Odaka M, Garcia JR, Port FK, Gaylin DS (1990) Five-year survival for endstage renal disease in patients in the United States, Europe and Japan, 1982 to 1987. Am J Kidney Dis 15: 451–457
Krolewski AS, Canessa M, Warram JH et al. (1988) Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 318: 140–145
Attman PO, Alaupovic P, Gustafson A (1987) Serum apolipoprotein profile of patients with chronic renal failure. Kidney Int 32: 368–375
Ritz E, Querfeld U (1989) Atherogenesis — is it accelerated in uremia? Seminars on Dialysis 2: 246–252
Cressman MD, Hoff HF, Nally JV, Schreiber M, van Lente F (1991) Lipoprotein and the cardiovascular risk of endstage renal disease. J Am Soc Nephrol 2: 234 (Abstract)
Author information
Authors and Affiliations
Additional information
On behalf of the study group “Diabetes and Uremia”. See Acknowledgements for list of participants
Rights and permissions
About this article
Cite this article
Koch, M., Thomas, B., Tschöpe, W. et al. Survival and predictors of death in dialysed diabetic patients. Diabetologia 36, 1113–1117 (1993). https://doi.org/10.1007/BF02374508
Issue Date:
DOI: https://doi.org/10.1007/BF02374508